CG Oncology, Inc. (CGON) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 41 transactions totaling $98.9M, demonstrating a bullish sentiment with $41.6M in net insider flow. The most recent transaction on Nov 17, 2025 involved a transaction of 1,000 shares valued at $600.
No significant insider buying has been recorded for CGON in the recent period.
No significant insider selling has been recorded for CGON in the recent period.
Based on recent SEC filings, insider sentiment for CGON is bullish with an Insider Alignment Score of 71/100 and a net flow of $41.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at CG Oncology, Inc. (CGON) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading CGON stock, having executed 41 transactions in the past 90 days. The most active insider is Brian Guan-chyun Liu (Executive), who has made 1 transactions totaling $50.0M.
Get notified when executives and directors at CGON file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | E. Post Leonard | Executive | Option Exercise | 1,000 | $0.60 | $600 | |
| Nov 17, 2025 | E. Post Leonard | Executive | Sale | 1,000 | $41.43 | $41.4K | |
| Oct 13, 2025 | E. Post Leonard | Executive | Option Exercise | 1,000 | $0.60 | $600 | |
| Oct 13, 2025 | E. Post Leonard | Executive | Sale | 1,000 | $43.25 | $43.3K | |
| Oct 9, 2025 | Mulay James | Executive | Option Exercise | 5,903 | $3.72 | $22.0K | |
| Oct 9, 2025 | Mulay James | Executive | Sale | 5,903 | $43.99 | $259.7K | |
| Sep 30, 2025 | E. Post Leonard | Executive | Sale | 5,000 | $40.09 | $200.4K | |
| Sep 30, 2025 | E. Post Leonard | Executive | Option Exercise | 5,000 | $0.60 | $3.0K | |
| Sep 29, 2025 | Mulay James | Executive | Sale | 12,755 | $39.19 | $499.9K | |
| Sep 29, 2025 | Mulay James | Executive | Option Exercise | 12,755 | $1.82 | $23.2K | |
| Sep 19, 2025 | Mulay James | Executive | Sale | 3,574 | $38.99 | $139.4K | |
| Sep 19, 2025 | Mulay James | Executive | Option Exercise | 3,574 | $1.82 | $6.5K | |
| Sep 18, 2025 | Mulay James | Executive | Sale | 19,112 | $39.01 | $745.6K | Large |
| Sep 18, 2025 | Mulay James | Executive | Option Exercise | 19,112 | $1.82 | $34.8K | |
| Sep 15, 2025 | E. Post Leonard | Executive | Option Exercise | 1,000 | $0.60 | $600 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 6 | $70.3M | 70.9% |
Sale(S) | 20 | $28.7M | 29.0% |
Exercise(M) | 11 | $109.3K | 0.1% |
Conversion(C) | 4 | $0 | 0.0% |
Insiders at CG Oncology, Inc. are accumulating shares at an accelerated pace. With 8 insiders making 41 transactions totaling $70.3M in purchases versus $28.7M in sales, the net buying activity of $41.6M signals strong executive confidence. Brian Guan-chyun Liu (Executive) leads the buying activity with $50.0M in transactions across all time.